Author:
Palla Amber Hanif,Khan Rafeeq Alam,Gilani Anwar H,Marra Fawziah
Abstract
AbstractBackgroundAlthoughGroup A beta hemolytic streptococcus (GABHS)can cause bacterial pharyngitis, the most common etiology is viral; despite this viral etiology, antibiotics are commonly prescribed for this infection in industrialized countries. We investigated the prevalence ofGABHSin adult pharyngitis patients from lower socioeconomic settings in Karachi, Pakistan, how often antibiotics are prescribed for pharyngitis and if appropriate agents were used in a developing world setting. Finally, we wanted to see the usefulness of modified McIsaac scores in predicting positive cultures.MethodsAdult patients were recruited from three local hospital outpatient dispensaries (OPDs). All patients aged 14–65 years who were suspected of having bacterial pharyngitis had throat swabs taken. Laboratory results forGABHSpharyngitis were then compared with their prescriptions. Appropriateness (using the World Health Organization’s definition) and type of antibiotic prescribed were assessed.ResultsOf 137 patients,30 patients each were studied for scores of 0, 1, 2 and 3; 17 patients were studied for score 4. Although 6 (4.4%) patients wereGABHS+, for a prevalence of 43.8 per 1000 population, antibiotics were prescribed to 135 patients (98.5%). Of these, only 11.1% received appropriate antibiotics while 88.9%received inappropriate antibiotics.Penicillins were prescribed most (34.1%), especially amoxicillin/clavulanate; followed by macrolides (31.1%), especially the second-generation agents, and fluoroquinolones (14.8%). McIsaac scores were found to be 100% sensitive and 68.7% specific, giving a positive predictive value (PPV) of 12.7% and a negative predictive value (NPV) of 100%.ConclusionsAntibiotics were prescribed irrationally to adult pharyngitis patients, as most cultures were negative for bacterial infection. McIsaac modification of Centor scores related directly to culture results. We would therefore highly recommend its use to help family physicians make treatment decisions for adult pharyngitis patients.
Publisher
Springer Science and Business Media LLC
Subject
Pulmonary and Respiratory Medicine
Reference35 articles.
1. Bertrand E, Gerard R: Comparison of hospital prevalence of rheumatic heart diseases and acute rheumatic arthritis in France and Africa. Arch Mal Coeur Vaiss. 1993, 86: 291-295.
2. Krober MS, Bass JW, Michels GN: Streptococcal pharyngitis: placebo-controlled double-blind evaluation of clinical response to penicillin therapy. JAMA. 1985, 253: 12714-
3. Report of a WHO Expert Consultation Geneva, 29 October–1 November 2001. WHO technical report series # 923. Rheumatic fever and Rheumatric heart disease. The role of the microbiology laboratory in the diagnosis of streptococcal infections and rheumatic fever. 2001, 50-51. (http://www.who.int/cardiovascular_diseases/resources/trs923/en/). PMID: 15382606
4. Woods WA, Carter CT, Stack M, et al: Group A streptococcal pharyngitis in adults 30 to 65 years of age. South Med J. 1999, 92 (5): 491-492. 10.1097/00007611-199905000-00008.
5. Infectious Diseases and Immunization Committee, Canadian Paediatric Society: Group A Streptococcus: a re-emergent pathogen. Can Med Assoc J. 1993, 148: 1909-1911.